By Karen Blum
Originally published by our sister publication Pharmacy Practice News
Measuring the urinary biomarkers neutrophil gelatinase-associated lipocalin (uNGAL) and kidney injury molecule-1 (uKIM-1) may be useful predictive tools alone or in combination to detect acute kidney injury (AKI) in populations such as critically ill children receiving vancomycin, according to a study presented at the 2022 ACCP Global Conference on Clinical Pharmacy, in San Freancisco.